Inventor · disambiguated record
Shuqian Xu
Also filed as: XU SHUQIAN
4 granted patents·5 pending applications·828 citations·filing 1996–2020
85Inventor score
Files withELAN PHARMA INT LTD4WEI MIN2CHILDRENS MEDICAL CT CORP1ELAN PHARMA INTERNATIONAL LIMI1NANOSYSTEMS LLC1
Top patents by PatentIndex Score
9 records- 0197US6045829ANanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizersELAN PHARMA INT LTD·Filed 1997·Granted Apr 4, 2000·329 cites·22 claims
- 0296US6221400B1Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitorsELAN PHARMA INT LTD·Filed 1999·Granted Apr 24, 2001·215 cites·13 claims
- 0393US6068858AMethods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizersELAN PHARMA INTERNATIONAL LIMI·Filed 1999·Granted May 30, 2000·232 cites·18 claims
- 0480US5705194APharmaceutical compositions containing polyalkylene block copolymers which gel at physiological temperatureNANOSYSTEMS LLC·Filed 1996·Granted Jan 6, 1998·52 cites·7 claims
- 0557US2008181957A1Increased amorphous stability of poorly water soluble drugs by nanosizingWEI MIN·Filed 2007·Application pending·0 cites
- 0656US2008299210A1Stable nanosized amorphous drugWEI MIN·Filed 2007·Application pending·0 cites
- 0750US2004258757A1Liquid dosage compositions of stable nanoparticulate active agentsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 0846US2022186218A1Methods and compositions for corrected aberrant splice sitesCHILDRENS MEDICAL CT CORP·Filed 2020·Application pending·0 cites
- 0945US2011165251A1Liquid dosage compositions of stable nanoparticulate active agentsELAN PHARMA INT LTD·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shuqian Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →